GlassScriptPhysician profile
Jill Schaeffer
NPI 1386626042
$4,201.16
in general payments reported to CMS, 2019-2025
12 companies · $539 in 2025
The $539 reported for 2025 was more than what 85% of Critical Care Medicine (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $937 · 2023: $474 · 2024: $2,096 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,609 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.39 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $1,050.00 | 2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $965.19 | 2022-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $800.65 | 2021-2025 | Accent, Jot Dx |
| Impulse Dynamics (USA) INC. | $600.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $233.95 | 2023 | Lifevest |
| Boston Scientific Corporation | $138.17 | 2024 | |
| Abiomed | $101.68 | 2023 | Impella |
| Biotronik INC. | $97.18 | 2023 | Biomonitor |
| Sanofi-Aventis U.S. LLC | $89.05 | 2022-2023 | |
| Pfizer INC. | $58.22 | 2025 | |
| Novartis Pharmaceuticals Corporation | $47.24 | 2024 | |
| Biosense Webster, INC. | $19.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.